Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Kidney (renal cell) cancer
Trial Type:  Treatment
Treatment/Intervention:  vaccine therapy
Results 1-6 of 6 for your search:
Start Over
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: AGS-003-007, NCI-2013-00717, 2012-000871-17, NCT01582672
Pidilizumab with or without Vaccine Therapy in Treating Patients with Stage IV Kidney Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-178, NCI-2012-00259, NCT01441765
A Rollover Protocol for Subjects Previously Treated With AGS-003
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: AGS-003-005, NCI-2011-03808, NCT01482949
Vaccine Therapy in Treating Patients with HER2-Positive Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-C-0016, NCI-2013-01564, 130016, P12990, NCT01730118
Immunotherapy Study for Metastatic Renal Cell Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NLG0106, NCI-2015-00313, NCT02035358
Vaccine Therapy before Surgery in Treating Patients with Localized Kidney Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 250113, NCI-2014-01254, AGS-003-012, NCT02170389
Start Over